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Abstract
Intestinal epithelial membrane transport of L-lactic acid was characterized using rabbit jejunal brush-border membrane
vesicles (BBMVs). The uptake of L-[14C]lactic acid by BBMVs showed an overshoot phenomenon in the presence of outward-
directed bicarbonate and/or inward-directed proton gradients. Kinetic analysis of L-[14C]lactic acid uptake revealed the
involvement of two saturable processes in the presence of both proton and bicarbonate gradients. An arginyl residue-
modifying agent, phenylglyoxal, inhibited L-[14C]lactic acid transport by the proton cotransporter, but not by the anion
antiporter. The initial uptakes of L-[14C]lactic acid which are driven by bicarbonate ion and proton gradients were inhibited
commonly by monocarboxylic acids and selectively by anion exchange inhibitor 4,4P-diisothiocyanostilbene-2,2P-disulfonic
acid and protonophore carbonylcyanide p-trifluoromethoxyphenylhydrazone, respectively. These observations demonstrate
that L-lactic acid is transported across the intestinal brush-border membrane by multiple mechanisms, including an anion
antiporter and a previously known proton cotransporter. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Monocarboxylic acids such as lactic acid and
short-chain fatty acids are well absorbed from the
small intestine and the underlying mechanisms are
considered to include both carrier-mediated trans-
port and passive di¡usion according to the pH-par-
tition hypothesis [1,2]. We have previously shown
that monocarboxylic acids such as acetic acid, nico-
tinic acid and the xenobiotic benzoic acid cross the
intestinal epithelial apical membrane via pH-depen-
dent mechanisms, including proton cotransport and
anion antiport, using isolated membrane vesicles and
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a human intestinal adenocarcinoma cell line, Caco-2
[3^9]. Furthermore, the monocarboxylate transporter
MCT has been demonstrated to exist in intestinal
epithelial cells and to facilitate pH-dependent trans-
port of pyruvic acid and lactic acid, especially at the
basolateral membrane [10,11]. In addition, we found
that MCT1 protein is also present at the brush-bor-
der membrane, where it may participate partially in
the absorption of monocarboxylic acids, causing an
apparent pH-dependent transport phenomenon in
the small intestine [12^14].
In renal epithelial cell membranes, anion exchange
transport for monocarboxylic acids operates [15] and
other organic anions also cross the renal epithelial
cell membrane via exchange transport mechanisms,
e.g., via the organic anion/dicarboxylic acid exchang-
er OAT [16]. Lactic acid was also suggested to par-
ticipate as one of the counter-anions to be exchanged
with urate at the renal epithelial apical membrane
[17]. Furthermore, we demonstrated that monocar-
boxylic acids are transported by an anion-exchange
transporter, AE2 [18], which is a well-known chlo-
ride/bicarbonate exchanger expressed in a variety of
tissues [19], including intestinal epithelial brush-bor-
der membrane [20]. We also found that transport of
lactic acid across Caco-2 cells could involve a bicar-
bonate/lactic acid antiport mechanism [21]. These ob-
servations suggest that lactic acid might be trans-
ported via an anion antiport mechanism in
intestinal epithelial brush-border membrane in paral-
lel with a proton-cotransport mechanism.
The purpose of the present study was to examine
whether a pH-dependent anion antiport system par-
ticipates in lactic acid transport across the intestinal
epithelial brush-border membrane, in addition to
with a proton-cotransport mechanism, using rabbit
jejunal brush-border membrane vesicles (BBMVs).
2. Materials and methods
2.1. Chemicals
L-[14C]Lactic acid (5.55 GBq/mmol) was purchased
from American Radiolabeled Chemicals (St. Louis,
MO). Valinomycin, p-chloromercuribenzenesulfonic
acid (PCMBS) and diethylpyrocarbonate (DEPC)
were purchased from Sigma Chemical (St. Louis,
MO). Pyridoxal-5P-phosphate (PLP) was purchased
from Boehringer-Mannheim (Germany). All other
chemicals were of reagent grade or the highest purity
available.
2.2. Membrane vesicle preparation and uptake study
The present study was performed according to the
Guidelines for the Care and Use of Laboratory Ani-
mals in Takara-machi Campus of Kanazawa Univer-
sity and was approved by the Committee on Animal
Experimentation of Kanazawa University, Takara-
machi Campus. Jejunal BBMVs of male rabbits
weighing 2.5^3.0 kg (Japan SLC, Shizuoka, Japan)
were isolated by the magnesium precipitation method
as described previously [8] and used on the day of
preparation. BBMVs were suspended in the medium
speci¢ed in 25 mM 2-[4-(2-hydroxyethyl)-1-piperazi-
nyl]ethanesulfonic acid (HEPES)-Tris bu¡er (pH 7.5)
containing either 30 mM KHCO3 or 30 mM K-gluc-
onate, to give a concentration of membrane protein
of 28.9 þ 3.7 mg/ml (n = 10, mean þ S.E.). The puri-
¢ed membrane preparation resulted in an alkaline
phosphatase enrichment of 10.0 þ 0.8-fold compared
with the crude mucosal homogenate (n = 10, mean
þ S.E.) [22]. The enrichment of (Na,K)-ATPase
activity was less than unity [23].
Uptake measurements were carried out by a rapid
¢ltration technique as described previously [6]. All
media containing bicarbonate were gassed for 1 h
with a 95% O2-5% CO2 mixture and the pH was
adjusted immediately before experiments. Other me-
dia were gassed with 100% O2 as a control for any
nonspeci¢c e¡ects of gassing. Uptake was initiated
by adding a 90 Wl aliquot of incubation medium con-
taining L-[14C]lactic acid to a 10 Wl aliquot of BBMV
suspension. Uptake of L-[14C]lactic acid was deter-
mined at 37‡C by incubating in 25 mM 2-(N-mor-
pholino)ethanesulfonic acid (MES)-Tris bu¡er (pH
6.0) or 25 mM HEPES-Tris bu¡er (pH 7.5) contain-
ing 30 mM K-gluconate and was terminated by the
addition of 1 ml of ice-cold stop solution, followed
immediately by ¢ltration on a 0.45 Wm ¢lter (HAWP,
Millipore, Bedford, MA). The ¢lter was washed
twice with 4 ml of ice-cold stop solution (25 mM
HEPES-Tris bu¡er, pH 7.5, 30 mM K-gluconate
and the appropriate concentration of mannitol to
be osmotically equivalent to the incubation medium).
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Initial uptake was evaluated in terms of the uptake at
10 s.
The amount of L-[14C]lactic acid taken up was de-
termined from the radioactivity. The ¢lters trapping
L-[14C]lactic acid were transferred to counting vials
and dissolved in 4 ml of scintillation £uid, Clear-sol I
(Nacalai Tesque, Kyoto, Japan) for quantitation in a
liquid scintillation counter. Protein was measured by
the method of Bradford [24] using a Bio-Rad protein
assay kit (Bio-Rad, Richmond, CA) with bovine se-
rum albumin as a standard.
2.3. E¡ect of an anion antiport inhibitor, a
protonophore and amino acid modi¢ers
The membrane vesicles were preloaded with
0.1 mM or 1 mM 4,4P-diisothiocyanostilbene-2,2P-di-
sulfonic acid (DIDS), or 0.02 mM carbonylcyanide
p-tri£uoromethoxyphenylhydrazone (FCCP) in
25 mM HEPES-Tris bu¡er (pH 7.5) containing ei-
ther 30 mM KHCO3 (bicarbonate gradient), 30 mM
KCl (chloride gradient) or 30 mM K-gluconate (pro-
ton gradient and no gradient) at room temperature
for 20 min. As the control, membrane vesicles were
similarly incubated without corresponding reagents.
After the incubation, the mixture was diluted and
centrifuged at 27 000Ug for 30 min. The ¢nal pellet
was suspended in experimental bu¡er. BBMVs were
treated with DEPC according to the method of Bind-
slev and Wright [25]. The membrane vesicles, sus-
pended in a bu¡er consisting of 100 mM mannitol
and 20 mM phosphate bu¡er (pH 6.5), were mixed
with 0.5 mM DEPC and then incubated at room
temperature for 10 min. The reaction of BBMVs
with 1 mM PCMBS and 25 mM phenylglyoxal
(PGO) was performed according to the method of
Miyamoto et al. [26]. The treatment with PCMBS
was performed in 20 mM phosphate bu¡er (pH
7.5) containing 300 mM mannitol and an equal con-
centration of ethylenediaminetetraacetic acid with
PCMBS in order to chelate free mercury, and then
the mixture was incubated at room temperature for
10 min. The treatment with PGO was performed in
the 20 mM phosphate bu¡er (pH 8.7) containing
280 mM mannitol and the mixture was incubated
at room temperature for 30 min. The reaction of
membrane vesicles with 25 mM PLP was done as
previously reported [27]. The membrane vesicles
were incubated with bu¡er containing 20 mM
MgCl2, 60 mM imidazole and 20 mM NH4Cl (pH
6.8) at room temperature for 15 min.
2.4. Data analysis
The uptakes were represented as uptake coe⁄cient
(Wl/10 s/mg protein), uptake rate (pmol/10 s/mg pro-
tein) or vesicle/medium ratio obtained by dividing
the uptake amount of L-lactic acid by the L-lactic
acid concentration in the incubation medium (Wl/mg
protein). The kinetic parameters for the uptake of
L-lactic acid by BBMVs were estimated by solving
the following equations, consisting of both saturable
and apparently nonsaturable linear terms, using the
nonlinear least-squares regression analysis program
MULTI [28].For a single saturable process and one
nonsaturable process:
v  VmaxUs=K t  s  kdUs
and for two saturable processes and one nonsatura-
ble process:
v  Vmax1Us=K t1  s  Vmax2Us=K t2  s
kdUs
where v and [s] represent the apparent uptake rate
and the concentration of L-lactic acid, respectively.
Vmax and Kt are the maximum uptake rate and the
apparent Michaelis constant for a saturable process,
respectively, and kd is the ¢rst-order rate constant for
the apparently nonsaturable component, which was
estimated from the uptake determined in the absence
of a bicarbonate gradient at pH 7.5.
3. Results
3.1. E¡ect of bicarbonate and/or proton gradients on
L-lactic acid uptake
Fig. 1 shows the time courses of uptake of L-
[14C]lactic acid in the presence and absence of proton
and/or bicarbonate gradients. In the presence of an
inward-directed proton or outward-directed bicar-
bonate gradient, uptake of L-[14C]lactic acid showed
an overshoot phenomenon, whereas in the absence of
any ion gradient, no signi¢cant increase of uptake
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was observed. The simultaneous imposition of the
two ion gradients, bicarbonate and proton gradients,
induced very e⁄cient uptake with a 10-fold increased
transient overshoot uptake over the uptake at the
steady state. The initial uptake measured at 10 s
(3.33 þ 0.22 Wl/mg protein) was larger than the sum
of the uptakes dependent on proton (1.59 þ 0.07 Wl/
mg protein) and bicarbonate (1.09 þ 0.06 Wl/mg pro-
tein) gradients.
3.2. Concentration dependence of L-lactic acid uptake
Fig. 2 shows the saturation kinetics of initial up-
take of L-lactic acid dependent on bicarbonate and/
or proton gradients, expressed as Eadie-Hofstee plots
after correction for nonsaturable uptake. Apparently
two saturable processes were involved in the presence
of both proton and bicarbonate gradients. The non-
linear least-squares analysis of the results yielded K t1
and K t2 values of 61.2 þ 58.8 mM and 2.1 þ 1.8 mM,
and Vmax1 and Vmax2 values of 60.9 þ 24.3 and
7.4 þ 5.7 nmol/10 s/mg protein, respectively. In the
presence of a proton or bicarbonate gradient alone,
a single saturable component was observed. The Kt
and Vmax values for proton and bicarbonate gra-
dient-driven uptakes were 43.1 þ 4.7 mM and
60.3 þ 5.6 nmol/10 s/mg protein and 11.3 þ 1.5 mM
and 16.0 þ 1.1 nmol/10 s/mg protein, respectively.
The nonsaturable uptake rate, kd, estimated in the
absence of a bicarbonate gradient at pH 7.5 was
0.274 þ 0.008 Wl/10 s/mg protein.
3.3. Anion speci¢city of the antiport process in
L-lactic acid uptake
Table 1 shows the anion dependence of L-
[14C]lactic acid transport at the intra- and extravesic-
ular pH of 7.5. Intravesicular chloride ion enhanced
L-lactic acid uptake as well as bicarbonate ion,
whereas the bivalent anion sulfate ion did not show
such an e¡ect. The enhancement of L-lactic acid
Fig. 2. Eadie-Hofstee plots for concentration dependence of L-
lactic acid uptake by rabbit jejunal BBMVs. BBMVs were pre-
loaded with 25 mM HEPES-Tris bu¡er (pH 7.5) containing ei-
ther 30 mM K-gluconate (closed symbols), or 30 mM KHCO3
(open symbols, for bicarbonate gradient). The incubation me-
dium contained 0.1^50 mM L-lactic acid, 30 mM K-gluconate,
25 mM MES-Tris bu¡er (pH 6.0, circles, for proton gradient)
or 25 mM HEPES-Tris bu¡er (pH 7.5, squares). Each solution
contained an appropriate concentration of mannitol to be iso-
tonic. All experiments were performed under identical condi-
tions to those described in the legend to Fig. 1. Each point rep-
resents the mean þ S.E. of three to four experiments after
correction for nonsaturable transport estimated from the uptake
at pH 7.5 in the absence of both bicarbonate and gradients.
Fig. 1. Time courses of L-[14C]lactic acid uptake by rabbit jeju-
nal BBMVs. BBMVs were preloaded with 25 mM HEPES-Tris
bu¡er (pH 7.5) containing either 30 mM K-gluconate (closed
symbols), or 30 mM KHCO3 (open symbols, for bicarbonate
gradient). The uptake of L-[14C]lactic acid (15 WM) was per-
formed at 37‡C by incubating in 25 mM MES-Tris bu¡er (pH
6.0, circles, for proton gradient) or 25 mM HEPES-Tris bu¡er
(pH 7.5, squares) containing 30 mM K-gluconate. Each solu-
tion contained an appropriate concentration of mannitol to be
isotonic. All experiments were performed in a medium contain-
ing 10 WM valinomycin and 1% ethanol (¢nal concentration).
Each point represents the mean þ S.E. of three to four experi-
ments.
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transport was reduced by DIDS, an anion exchange
inhibitor.
3.4. E¡ect of an anion antiport inhibitor,
a protonophore and amino acid modi¢ers on
L-lactic acid uptake
Table 2 shows the e¡ect of an anion antiport in-
hibitor, protonophore and chemical modi¢ers of the
amino acid residues that are functionally important
for L-lactic acid transport. The uptake of L-[14C]lactic
acid was inhibited by 0.1 mM of DIDS only in the
presence of bicarbonate gradient, and by a protono-
phore, FCCP, at the concentration of 0.02 mM only
in the presence of proton gradient. The uptake of L-
[14C]lactic acid was inhibited by histidyl (DEPC),
thiol (PCMBS) and lysine (PLP) residue-modifying
agents both in the presence of bicarbonate ion and
proton gradients, whereas PGO, an arginyl residue-
modifying agent, inhibited only proton cotransport
of L-[14C]lactic acid, but not an anion antiport.
3.5. Inhibitory e¡ects of various compounds on lactic
acid uptake
The substrate speci¢city of lactic acid transport by
bicarbonate antiport was examined by the inhibitory
e¡ects of various compounds and compared with
that of proton cotransport. As shown in Table 3,
L-[14C]lactic acid uptake facilitated by a bicarbonate
gradient was reduced by various monocarboxylic
acids, but not by acetamide, succinic acid or citric
acid. In addition, stereoselectivity in the inhibition of
L-[14C]lactic acid uptake by L- (36.3% of the control)
and D-lactic acid (68.6%) was observed. In the pres-
ence of proton gradient, L-[14C]lactic acid uptake was
reduced by various carboxylic acids but not by acet-
amide. However, the observations of the signi¢cant
inhibition by succinic acid and citric acid and the
absence of stereoselectivity in the inhibitory e¡ect
of L- and D-lactic acids are distinct from the charac-
teristics of bicarbonate ion-dependent lactic acid
transport.
Table 2
E¡ects of a anion antiport inhibitor, a protonophore and ami-
no acid modi¢ers on the initial uptake of L-[14C]lactic acid
Inhibitors (conc.) Relative uptake (% of control)
Bicarbonate gradient Proton gradient
DIDS (0.1 mM) 74.1 þ 2.4* 101.6 þ 1.7
FCCP (0.02 mM) 92.9 þ 6.9 29.5 þ 0.7*
DEPC (0.5 mM) 41.3 þ 1.1* 86.9 þ 1.3*
PCMBS (1 mM) 55.5 þ 2.9* 51.6 þ 2.7*
PLP (25 mM) 51.2 þ 3.8* 56.7 þ 2.1*
PGO (25 mM) 97.5 þ 6.6 38.8 þ 2.0*
The preload condition with DIDS, FCCP and amino acid
modi¢ers is mentioned in Section 2. The uptake of L-[14C]lactic
acid was performed at 37‡C by incubating in 25 mM HEPES-
Tris bu¡er (pH 7.5) containing 30 mM K-gluconate for the bi-
carbonate gradient-dependent uptake, or 25 mM MES-Tris
bu¡er (pH 6.0) containing 30 mM K-gluconate for the proton
gradient-dependent uptake. Each solution contained an appro-
priate concentration of mannitol to be isotonic. All experiments
were performed under identical conditions to those described in
the legend to Fig. 1. Each value represents the mean þ S.E. of
three to four experiments.
*Signi¢cantly di¡erent from the control value by Student’s t-
test (P6 0.05).
Table 1
E¡ect of intravesicular anion and anion transport inhibitors on
L-[14C]lactic acid uptake by rabbit jejunal BBMVs
Driving force Relative uptake (% of control)
Gluconate (control) 100
Bicarbonate 166.2 þ 9.3*
+1 mM DIDS 88.9 þ 4.6*;**
Chloride 168.6 þ 11.6*
+1 mM DIDS 115.0 þ 16.2**
Sulfate 112.5 þ 6.7
BBMVs were preloaded with 25 mM HEPES-Tris bu¡er (pH
7.5), containing 30 mM KHCO3 (for bicarbonate gradient),
KCl (for chloride gradient), K2SO4 (for sulfate gradient), or K-
gluconate (for control). The preload condition with DIDS is
mentioned in Section 2. The uptake of L-[14C]lactic acid was
performed by incubating in HEPES-Tris bu¡er (pH 7.5) and
adding 30 mM K-gluconate, except for the sulfate gradient, for
which 60 mM K-gluconate was added to adjust the K concen-
tration at either side of the membrane. Each solution contained
an appropriate concentration of mannitol to be isotonic. All ex-
periments were performed under identical conditions to those
described in the legend to Fig. 1. Each value represents the
mean þ S.E. of three to four experiments.
*Signi¢cantly di¡erent from the uptake value in the absence of
any gradient by Student’s t-test (P6 0.05).
**Signi¢cantly di¡erent from the uptake value in the absence of
DIDS under each condition by Student’s t-test (P6 0.05).
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4. Discussion
Although it has long been believed that lactic acid
is absorbed from the small intestine mainly by pas-
sive di¡usion [29], precise studies on membrane
transport mechanisms have demonstrated the in-
volvement of carrier-mediated transport mechanisms
driven by sodium and/or proton gradients across the
intestinal epithelial brush-border membrane [30^32].
Since the ¢nding of proton/lactic acid cotransporter
MCTs [10,11], we suggested the partial role of MCT1
as the intestinal monocarboxylic acid transporter
[12^14]. However, the results of our membrane phys-
iological studies of monocarboxylic acids indicated
that an anion antiport mechanism might also be in-
volved in the brush-border membrane transport of
monocarboxylic acids in the small intestine
[4,8,9,18]. In the present study, using isolated mem-
brane vesicles, it was demonstrated that an anion
antiport and proton cotransport mechanism does
participate in the transport of lactic acid across the
intestinal brush-border membrane.
In the presence of outward-directed bicarbonate
and/or inward-directed proton gradients, the uptake
of L-lactic acid by isolated rabbit jejunal BBMVs
showed an overshoot uptake (Fig. 1). Uptake of
L-lactic acid in the presence of both bicarbonate
ion and proton gradients appeared to involve multi-
ple transport systems, while Eadie-Hofstee plot anal-
ysis in the presence of either a bicarbonate or a pro-
ton gradient suggested that only a single mechanism
functions in each case (Fig. 2). In addition, bicarbon-
ate ion-dependent uptake of L-lactic acid was inhib-
ited by an anion exchange inhibitor, DIDS, but not
by a protonophore FCCP (Table 2). Furthermore,
the absence of stereoselectivity in the inhibitory ef-
fects of L- and D-lactic acid and the signi¢cant reduc-
tion of L-lactic acid uptake in the presence of succinic
acid and citric acid were observed only in the proton
gradient-dependent uptake of L-lactic acid (Table 3).
These results strongly demonstrated that there are
multiple pathways for L-lactic acid transport that
function independently in the intestinal epithelial
brush-border membranes, namely a bicarbonate/lac-
tic acid antiporter and a proton-lactic acid cotrans-
porter. An arginyl residue was suggested to be in-
volved in the functional domain of the proton
cotransporter, but not of the anion antiporter, since
an arginyl residue-modifying agent, PGO, inhibited
only proton-dependent transport of L-[14C]lactic
acid. This speci¢c inhibitory e¡ect provides addition-
al evidence that lactic acid is transported by an anion
antiport mechanism, which is distinct from the pro-
ton cotransport mechanism.
Kinetic analysis of the proton gradient-dependent
uptake of L-lactic acid transport at the extravesicular
pH of 6.0 gave a Kt of 43.1 mM, and this system
seems to correspond to the low-a⁄nity component
(K t2 , 61.2 mM) observed in the presence of both
proton and bicarbonate gradients. Accordingly, the
higher-a⁄nity component (K t1 , 2.1 mM) obtained at
pH 6.0 in the presence of a bicarbonate gradient is
thought to represent the bicarbonate gradient-depen-
dent uptake of L-lactic acid. The Kt value at pH 7.5
in the presence of a bicarbonate gradient alone
(11.3 mM) was comparable with the reported Kt val-
ue for the anion antiport of L-lactic acid across
Caco-2 cells (10.9 mM) [21]. The obtained Kt value
Table 3
Inhibitory e¡ects of various carboxylic acids on the initial up-
take of L-[14C]lactic acid
Carboxylic acids Relative uptake (% of control)
Bicarbonate gradient Proton gradient
Acetic acid 11.3 þ 1.9* 45.5 þ 1.9*
D-Lactic acid 68.6 þ 7.8*;** 54.0 þ 3.8*
L-Lactic acid 36.3 þ 1.1*;** 50.6 þ 2.4*
Nicotinic acid 1.5 þ 2.2* 38.7 þ 3.3*
Valproic acid ND* 33.5 þ 1.5*
Acetamide 81.8 þ 6.6 90.7 þ 1.9
Citric acid 98.8 þ 4.1 77.3 þ 3.5*
Succinic acid 107.4 þ 2.0 53.8 þ 5.5*
BBMVs were preloaded with 25 mM HEPES-Tris bu¡er (pH
7.5) containing either 30 mM KHCO3 for bicarbonate gradient
or 30 mM K-gluconate for proton gradient. Each solution con-
tained an appropriate concentration of mannitol to be isotonic.
The concentration of each inhibitor was 20 mM. All experi-
ments were performed under identical conditions to those de-
scribed in the legend to Fig. 1. Each value represents the
mean þ S.E. of three to four experiments as a percentage of the
control uptake. Uptake coe⁄cients of the control studies for bi-
carbonate exchange and proton cotransport, corrected for the
uptake in the absence of any ion gradient, were 1.07 þ 0.049
and 1.36 þ 0.083 (Wl/10 s/mg protein, mean þ S.E.), respectively.
*Signi¢cantly di¡erent from the control value by Student’s t-
test (P6 0.05).
**Signi¢cant di¡erence between isomers by Student’s t-test
(P6 0.05).
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(11.3 mM) is apparently larger than the higher-a⁄n-
ity component K t1 2.1 mM in the presence of both
bicarbonate and proton gradients. The smaller Kt
value (2.1 mM) may be explained by the pH depen-
dence of the anion antiport process. Because anion
antiport of monocarboxylic acids could be facilitated
at acidic pH 6.0 compared with that at neutral pH as
observed previously for the transport of other mono-
carboxylic acids in isolated BBMVs [8]. So, the K t1 is
expected to represent the Michaelis constant of the
anion antiporter at acidic pH. In addition, the initial
uptake measured at pH 6.0 in the presence of an
outward bicarbonate ion gradient (3.3 Wl/mg pro-
tein/10 s) was larger than the sum of the uptakes
(2.68) observed in the presence of proton (1.59)
and bicarbonate (1.09) gradients. These results
strongly suggest an activation of the anion antiporter
at the physiological (acidic) pH.
The inhibitory e¡ect of various compounds sug-
gested that several monocarboxylic acids might be
substrates for the common anion antiporter with
L-lactic acid (Table 3). It was also indicated that
chloride ion can behave as a counter-anion for L-
lactic acid uptake in BBMVs, the same as bicarbon-
ate ions for the anion antiporter. Previously, we
showed that uptake of monocarboxylic acids medi-
ated by an anion exchange transporter AE2 was in-
hibited by extracellular chloride ion, bicarbonate ion
and DIDS, and was activated by extracellular acid-
i¢cation [18]. We preliminarily observed the expres-
sion of uptake activity of L-[14C]lactic acid by AE2-
expressing cells (data not shown). So, since there is
one report of the presence of AE2 in the intestinal
brush-border membrane [20], AE2 or related trans-
porter might be involved as anion antiporter for lac-
tic acid. Recently, another anion exchanger, DRA,
which is expressed in the brush-border membranes of
intestine, highly in colon, was demonstrated [33,34].
Functionally DRA is characterized by transporting
sulfate ions by anion exchange mechanism [35,36].
Since uptake of lactic acid was not enhanced by pre-
loading sulfate ions in the present study (Table 1), it
is unlikely that DRA is involved in the lactic acid/
anion antiporter in rabbit small intestine. Further
studies are essential for the molecular identi¢cation
of anion antiporter for L-lactic acid in the intestinal
epithelial brush-border membrane.
Proton gradient-dependent transport of L-lactic
acid was clearly demonstrated to be involved inde-
pendently from the anion antiport as discussed
above. We have previously demonstrated that mono-
carboxylic acid transporter MCT1 is partially con-
tributed to the intestinal absorption of various com-
pounds [12^14]. However, several observations in the
present study, including the Km value (Fig. 2), ab-
sence of stereospeci¢city for L- and D-lactic acids,
and apparent inhibition by di- and tricarboxylic
acid (Table 3), were not completely consistent with
previously known MCT1 [7,8,37^39], although rabbit
MCT1 has not been functionally characterized yet.
So, it is probable that unknown transporters such as
MCT isoforms or others might be involved as the
proton cotransporter for lactic acid.
Cheeseman et al. [40] demonstrated that a lactic
acid transporter in the rat intestinal basolateral mem-
brane operates as an anion exchanger. They showed
that several monocarboxylic acids are transported in
a similar manner, which was in£uenced by a bicar-
bonate gradient, but not by a pH gradient or by
DIDS. The anion antiporter and the proton cotrans-
porter that are presumed to exist both in brush-bor-
der and basolateral membranes may regulate the
overall membrane transport process of lactic acid
in the intestine.
In conclusion, the present study demonstrated that
an anion antiporter is involved in the transport of
L-lactic acid across the intestinal brush-border mem-
brane in parallel with a proton cotransporter. Since
intracellular bicarbonate ions and intestinal luminal
protons are supplied by the cytoplasmic carbonic
anhydrase and by microclimate pH due to sodium/
proton antiport [41], respectively, these transporters
are expected to function e⁄ciently for the intestinal
absorption of L-lactic acid.
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